Arthur Levinson

CEO of Calico, Chairman of Apple

Arthur D. Levinson has been Chairman of Genentech since September 1999 and served as Chief Executive Officer of Genentech from July 1995 to April 2009. In September 2013, Levinson was named Chief Executive Officer of Calico, a company focused on health, aging, and well-being. Levinson serves as the Chairman of the Board of Apple and the Chairman of the Board of Amyris. He is a director of Roche, NGM Biopharmaceuticals, and the Broad Institute of MIT and Harvard. Levinson previously served as a director of Google from 2004 to 2009. In addition, Levinson currently serves on the Board of Scientific Consultants of the Memorial Sloan-Kettering Cancer Center, the Industrial Advisory Board of the California Institute for Quantitative Biomedical Research, the Advisory Council for the Princeton University Department of Molecular Biology and the Advisory Council for the Lewis-Sigler Institute for Integrative Genomics.

Levinson has authored or co-authored more than 80 scientific  articles and has been a named inventor on 11 United States  patents. Levinson received the Irvington Institute's 1999 Corporate  Leadership Award in Science and was honored the same year with  the Corporate Leadership Award from the National Breast Cancer  Coalition. He was inducted into the Biotech Hall of Fame at the  2003 Biotech Meeting of chief executive officers. BusinessWeek  named Levinson one of the “Best Managers of the Year” in 2004  and 2005, and Institutional Investor named him “America’s Best  CEO” in the biotech category four years in a row (2004-2007). In  2006, Princeton University awarded Levinson the James Madison  Medal for a distinguished career in scientific research and in  biotechnology. Also in 2006, Barron’s recognized Levinson as  one of “The World’s Most Respected CEOs,” and the Best Practice  Institute placed Levinson on their “25 Top CEOs” list. In 2008,  Levinson was elected as a Fellow to the American Academy of  Arts & Sciences. 

Levinson received his Bachelor of Science degree in molecular  biology from the University of Washington and earned a doctorate in Biochemical Sciences from Princeton University.